Search – Page 215 – Indianapolis Business Journal

Home » Search

Articles

The surprising new use for GLP-1s: Alcohol and drug addiction

November 17, 2025 | The Washington Post

As GLP-1 drugs for weight loss and diabetes drugs such as Zepbound and Mounjaro generate billions in sales, researchers at Eli Lilly and Co. and other pharma companies are exploring their potential for other purposes.

Lilly to open Gateway Labs site in Philadelphia

November 19, 2025 | Daniel Lee

Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.

Lilly joins $1 trillion club as weight-loss drugs fuel stock surge

November 21, 2025 | Bloomberg News

It’s just the latest landmark for Indianapolis-based Lilly, which was catapulted into the top spot as the world’s largest health care company by market capitalization in 2023.

Dennis Bland keeps Center for Leadership Development—and the kids it serves—moving forward

November 21, 2025 | Sam Stall

For that devotion, and for a lifetime spent quietly strengthening the city around him, IBJ has named Bland the 32nd recipient of the Michael A. Carroll Award.

Property owners receive letters seeking easements for $560M Lebanon Water Supply Program

November 26, 2025 | Daniel Bradley

Citizens Energy said Eagle Creek will be one of 10 water sources that will be part of the supply program, which will provide 25 million gallons of water per day to Lebanon and the LEAP District by 2031.

Lilly rolling out direct-to-employer obesity drug coverage

November 26, 2025 | Daniel Lee

The Indianapolis-based drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers.

Downtown post office property once again stirs what-ifs

November 28, 2025 | Mickey Shuey

For 20 years, every mayoral administration has explored taking over or facilitating the sale of the post office directly east of Lucas Oil Stadium—with each attempt failing to gain traction.

Lilly cuts prices on Zepbound vials sold on LillyDirect

December 1, 2025 | Daniel Lee

The decision is the latest in a series of moves to make its GLP-1 blockbuster more widely available and affordable.

Lilly, IU sign clinical trial, research agreement worth up to $40M

December 3, 2025 | Daniel Lee

Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.

Editorial: Proposed congressional districts hurt anchor of state’s economy

December 5, 2025

Indianapolis voters need the ability to send a representative to Congress who will advocate for the city, its people and the many corporate headquarters—Eli Lilly and Co., Elevance Health, Roche Diagnostics, Corteva, Simon Property Group and others—located here.

Lilly to build $6B plant in Alabama in 3rd of 4 big US investments

December 9, 2025 | Daniel Lee

Lilly’s planned Huntsville site is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 billion reshoring investment unveiled early this year.

Claire Fiddian-Green: Navigating AI’s impact, personally and professionally

December 12, 2025 | Claire Fiddian-Green

The good news is that Indiana is an early adopter of AI tools in K-12 education.

State health insurance plan changes reflect Braun’s vision

December 12, 2025 | Daniel Lee

For 2026, the plan features significantly lower out-of-pocket costs for members who use the plan’s “narrow network” that limits choice.

Citizens Energy ready to start work on Lebanon water project

December 12, 2025 | Daniel Bradley

Construction is set to begin early next year on a $560 million project to send millions of gallons of water each day to Lebanon to meet the demands of the state’s 9,000-acre LEAP Research and Innovation District.

Lilly Phase 3 trial shows GLP-1 pill effective for weight-loss maintenance

December 18, 2025 | Daniel Lee

According to the study, orforglipron users maintained their weight loss levels more closely after previously taking a rival’s GLP-1 injectable, the Indianapolis-based drugmaker said.

Lilly’s growth explosion tests state’s workforce development

December 19, 2025 | Daniel Lee

Eli Lilly and Co.’s career website this month listed 254 job openings in Indianapolis and another 90 in Lebanon, accounting for more than three-quarters of the 445 open positions the pharmaceutical giant listed across the United States.

Republicans and Democrats pitch competing plans to tackle affordability

December 22, 2025 | The Washington Post

Lawmakers in both parties view simmering fury over the cost of living as the top issue in next year’s midterm elections and are pitching a growing profusion of proposals to tackle the notoriously difficult problem of affordability.

US regulators approve Wegovy pill for weight loss, giving Novo Nordisk an edge over Lilly

December 22, 2025 | Associated Press

Novo Nordisk’s Wegovy pills are expected to be available within weeks, while Indianapolis-based Eli Lilly and Co. waits for approval for its daily GLP-1 pill, orforglipron.

2025 Newsmaker: Jeff Simmons

December 26, 2025

Jeff Simmons has been CEO of Elanco since its spinoff from Eli Lilly and Co. in 2018, guided the company’s 2020 acquisition of Bayer Animal Health and has overseen the development of drugs that are starting to pay off in profits and investor confidence.

2025 Newsmaker: David Ricks

December 26, 2025 | IBJ Staff

As of Nov. 13, Eli Lilly and Co.’s market capitalization was $967 billion and flirting with a rare $1 trillion. Its stock price in November surpassed $1,000 per share, up more than 25% for the year.

« Previous 1 … 213 214 215 216 217 … 221 Next »

Search Results

4,409 results for '\"eli lilly\"'